Dr. Kim Branson is Senior Vice President and the Global Head of Artificial Intelligence & Machine Learning at GSK, where he leads a global team developing and applying AI methods that accelerate drug discovery and clinical development across GSKPrior to joining GSK in 2019, he served as Head of AI for Genentech and is a serial entrepreneur having previously co-founded multiple successful startups with exits including Twitter and Apple Dr. Branson earned degrees from the University of Adelaide, completed his PhD at the University of Melbourne, and undertook post-doctoral training at Stanford University establishing a deep technical foundation at the intersection of machine learning, structural biology, medicine and drug discovery.